NPPES file of Aug 9, 2026

Azhar Afaq, M.D.

Endocrinology, Diabetes & Metabolism Physician · Fort Worth, TX

Azhar Afaq, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Fort Worth, Texas, and NPI 1518906569, issued on Jun 5, 2006. Check the license (Texas L0967, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1518906569
Name
Azhar Afaq
Credential
M.D.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License numbers
L0967 TX
21523 OK
Self-reported in NPPES; status is on the state search
Practice location
1617 Hemphill St, Fort Worth, TX 76104
Phone
(817) 927-3941
Enumerated
Jun 5, 2006
Record last updated
Jun 24, 2016 (not updated in 10 years: call before relying on the address or phone)
Medicare enrollment
Enrolled (PECOS I20090731000259); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1617 Hemphill St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Ashley Baillio, ACNPAcute Care Nurse Practitioner1215395405
  2. Amy Birchfield, R.N.C., NNP-BCNeonatal Nurse Practitioner1679769392
  3. Cynthia Claassen, PHDPsychologist1487616561
  4. Bryan Duncan, L.P.C.Clinical Psychologist1891937900
  5. Yukyung Jung, M.D.Child & Adolescent Psychiatry Physician1164782256
  6. Sandra Landry, APRNPsychiatric/Mental Health Nurse Practitioner1396295044

Verify Azhar Afaq in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license L0967
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

63% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

972 Medicare Part D claims for 227 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 47% of claims.

  1. Azhar Afaq972
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium229 claims
  2. Alendronate Sodium54 claims
  3. Trulicity52 claims
  4. Tresiba Flextouch U-10037 claims
  5. Lantus Solostar35 claims
  6. Jardiance32 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualitynot scored (reweighted)
  2. Costnot scored (reweighted)
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $514.79

4 payments; by number, the most common kind was food and beverage; the largest payer was Medtronic, Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Azhar Afaq$514.79
  2. Specialty average$5,742.15

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 3 group practices

  1. Acclaim Physician Group IncArlington, TX
  2. Hospitalist Medicine Physicians OF Texas PLLCFort Worth, TX
  3. Prmc Healthcare Group, Inc.Paris, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Azhar Afaq among 743 endocrinology, diabetes & metabolism physician records in Texas

Azhar Afaq, M.D. is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 6% of them.

  • NPI issued2006 · 6% of these records are older, 61% newer
  • In a Medicare fileYes · 87% of these records are
  • In the CMS Doctors and Clinicians fileYes · 75% of these records are
  • Graduated1994 · median 2004 among the 560 with a school on file
  • Record last updated2016 · 50% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Texas

There are 743 endocrinology, diabetes & metabolism physician records in Texas.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Mary Cox, M.D.Fort Worth, TX 761041104042035
  2. James Dunn, MDFort Worth, TX 761041518929918
  3. Franklin Gluck, M.D.Fort Worth, TX 761041154421055
  4. Stella Hecker, MDFort Worth, TX 761041467484741
  5. Naveed Khanjee, MDFt Worth, TX 761041942736046
  6. Kenneth Mair, M.D.Fort Worth, TX 761041588696678
  7. Saraswathi Saiprasad, MDFort Worth, TX 761041588977102
  8. Petchpailin SittiratFort Worth, TX 761041871175083

Common questions

What is Azhar Afaq, M.D.'s NPI number?

Azhar Afaq, M.D.'s National Provider Identifier (NPI) is 1518906569, issued on Jun 5, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Azhar Afaq, M.D. located?

The NPPES record lists a practice address at 1617 Hemphill St, Fort Worth, TX, 76104. Phone: (817) 927-3941. Providers update this record themselves, so call before visiting.

How can I verify Azhar Afaq, M.D.'s license?

NPPES lists Texas license number L0967, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Azhar Afaq, M.D. prescribe under Medicare Part D?

In 2024, Azhar Afaq, M.D. had 972 Medicare Part D claims for 227 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Azhar Afaq, M.D.'s MIPS final score?

The 2023 MIPS final score is 100 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.